Picture Berlin Partner Hotspot for Startups 650x80px

Person › Details

Ugur Sahin (BioNTech AG)

Sahin, Ugur (BioNTech 201207 Managing Director BioNTech + Ribological GmbH)

	Organisation	BioNTech AG
	Today	BioNTech SE (Nasdaq: BNTX)
	Group	BioNTech (Group)
	Former/major organisation	Ribological GmbH
	Today	BioNTech RNA Pharmaceuticals GmbH
	Group	BioNTech (Group)
	Product	drug discovery
	Product 2	cancer drug

Record changed: 2020-12-30

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Ugur Sahin

[1] BioNTech SE. (5/10/21). "Press Release: BioNTech to Establish Regional Headquarters for Southeast Asia and First mRNA Manufacturing Facility in Singapore". Mainz....
[2] BioNTech SE. (12/29/20). "Press Release: Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of Comirnaty". New York, NY & Mainz....
[3] BioNTech SE. (12/23/20). "Press Release: Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine". New York, NY & Mainz....
[4] BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine". New York, NY & Mainz....
[5] BioNTech SE. (12/21/20). "Press Release: Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine". New York, NY & Mainz....
[6] BioNTech SE. (12/16/20). "Press Release: BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine". Mainz & Shanghai....
[7] BioNTech SE. (12/12/20). "Press Release: U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older". New York, NY & Mainz....
[8] BioNTech SE. (12/11/20). "Press Release: Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19". New York, NY & Mainz....
[9] BioNTech SE. (11/25/20). "Press Release: BioNTech and InstaDeep Announce Strategic Collaboration and Form AI Innovation Lab to Develop Novel Immunotherapies". Mainz & London....
[10] BioNTech SE. (11/11/20). "Press Release: Pfizer and BioNTech Reach an Agreement to Supply the EU with 200 Million Doses of Their BNT162b2 mRNA-based Vaccine Candidate against COVID-19". New York, NY & Mainz....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

» top